Philippines to receive 300,000 courses of Merck's COVID-19 pill - (National Post via NewsPoints Desk)

  • The Philippines will receive 300,000 courses of Merck & Co’s COVID-19 antiviral drug molnupiravir next month, licensed importers and distributors said on Wednesday, as reported by the National Post.

  • Singapore and Malaysia have also signed deals to buy the drug, while Indonesia is finalizing a purchase agreement, among a slew of orders after data from interim clinical trials showed the pills could halve the likelihood of hospitalization or death for patients at risk of severe COVID-19.

  • Monaliza Salian, president of MedEthix, a Philippine healthcare products importer, said the company will import 300,000 courses of molnupiravir for COVID-19 patients in four hospitals. 

  • Each pill is estimated to cost 100 to 150 pesos ($1.97 to $2.96), according to Meneleo Hernandez, president of JackPharma, which will distribute the drug locally.

  • The Philippines has approved the "compassionate use" of molnupiravir for 31 hospitals, FDA Chief Rolando Enrique Domingo said on Wednesday.

To read more NewsPoints articles, click here.